Mark W. Lingen to Endothelial Cells
This is a "connection" page, showing publications Mark W. Lingen has written about Endothelial Cells.
Connection Strength
0.285
-
Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growth. Cancer Res. 2007 Oct 15; 67(20):9685-93.
Score: 0.063
-
Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1. J Biol Chem. 2007 Jul 06; 282(27):19781-7.
Score: 0.061
-
Recombinant human uteroglobin/CC10 inhibits the adhesion and migration of primary human endothelial cells via specific and saturable binding to fibronectin. J Cell Physiol. 2006 May; 207(2):553-61.
Score: 0.057
-
Synthetic peptides derived from the angiostatin K4 domain inhibit endothelial cell migration. Chembiochem. 2003 Nov 07; 4(11):1238-42.
Score: 0.048
-
A novel Peptide to treat oral mucositis blocks endothelial and epithelial cell apoptosis. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):e409-15.
Score: 0.021
-
VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2. Cell Death Differ. 2010 Mar; 17(3):499-512.
Score: 0.018
-
A novel interplay between Epac/Rap1 and mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) regulates thrombospondin to control angiogenesis. Blood. 2009 Nov 12; 114(20):4592-600.
Score: 0.018